Stereotaxis is trading at $0.88, down 8.08%, as a broad market sell-off makes wider risk-off sentiment the likeliest context; no company catalyst is confirmed.
- No company-specific announcement dated November 5 was identified; the company’s release listing shows its latest release dated November 2.
- Stereotaxis is scheduled to report third-quarter results on November 10.